FDA clears the way for additional bivalent boosters for certain vulnerable individuals

[ad_1]
The U.S. Food and Drug Administration has reaffirmed its emergency use authorizations for the Pfizer and Moderna bivalent vaccines, allowing people 65 and older and certain people with weakened immunity to get additional doses before this fall’s vaccination campaigns.

[ad_2]